Stroke-recovery device using brain-computer interface receives FDA market authorization
Treating neurological symptoms of CHARGE syndrome
28 April 2021Why variants are most likely to blame for India’s COVID surge
28 April 2021Stroke-recovery device using brain-computer interface receives FDA market authorization
A first-of-its kind device that helps people disabled by stroke regain significant control over their arm and hand function by using their minds has received market authorization from the Food and Drug Administration (FDA). The IpsiHand Upper Extremity Rehabilitation System, developed by Neurolutions Inc.—a Washington University in St. Louis startup company—leverages brain-computer interface (BCI) technology licensed from the university.
